文献速递血液净化与透析

基于医疗保险索赔数据的腹膜透析相关腹膜炎趋势,2013-2017年

Peritoneal Dialysis-Associated Peritonitis Trends Using Medicare Claims Data, 2013-2017.
PubMed 文献 · Am J Kidney Dis · 2022-09-12

该回顾性队列研究利用美国肾脏数据系统索赔数据,纳入2013至2017年间接受腹膜透析且享有医疗保险按服务付费保险的患者,识别腹膜炎 episode 并分析其率与趋势。总体腹膜炎率为每患者年0.54次,率每年下降5%,且随年龄增长而降低、黑人高于白人高于亚裔、既往腹膜炎次数越多率越高。

要点

  • 总体腹膜炎率为0.54次/患者年,排除导管代码后为0.45次/患者年,仅限肾脏科或透析提供者索赔时为0.35次/患者年。
  • 腹膜炎率每年下降5%,且老年患者率更低,黑人率高于白人高于亚裔,既往腹膜炎次数越多率越高。
  • 40%的腹膜炎 episode 仅来自门诊,9%仅来自住院,16%仅基于不能明确区分腹膜炎与导管感染的导管代码。

核心结论

  • 腹膜透析相关腹膜炎率随时间下降,且老年患者中更低。
  • 基于索赔数据的方法为研究腹膜透析相关腹膜炎提供了有前景的框架。

研究设计与样本

  • 回顾性队列研究,使用美国肾脏数据系统标准分析文件中的索赔、资格、模式与人口学信息。
  • 样本为2013至2017年间接受腹膜透析、享有医疗保险按服务付费保险并有透析或医院服务付费索赔的患者。
  • 从396289条腹膜炎索赔中识别出70271次腹膜炎 episode。

主要发现

  • 腹膜炎 episode 常由多条聚合索赔识别,每 episode 平均5.6条、中位2条索赔。
  • 40%的 episode 仅来自门诊,9%仅来自住院,16%仅基于不能明确区分腹膜炎与导管感染/炎症的导管代码。
  • 总体腹膜炎率为0.54次/患者年,排除导管代码后为0.45次/患者年,仅限肾脏科或透析提供者索赔的 episode 时为0.35次/患者年。
  • 腹膜炎率每年下降5%,且随年龄增长而降低、黑人高于白人高于亚裔、每增加一次既往腹膜炎 episode 率更高。

关键数值与推荐

  • 腹膜炎通过ICD-9和ICD-10诊断代码识别,间隔30天内的腹膜炎索赔聚合为1次 episode。
  • 患者水平腹膜炎风险因素使用泊松回归建模。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 编码异质性表明缺乏标准化。
  • 仅基于导管代码的 episode 可能代表假阳性。
  • 腹膜炎 episode 未针对症状或微生物学数据进行验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: The occurrence and consequences of peritoneal dialysis (PD)-associated peritonitis limit its use in populations with kidney failure. Studies of large clinical populations may enhance our understanding of peritonitis. To facilitate these studies we developed an approach to measuring peritonitis rates using Medicare claims data to characterize peritonitis trends and identify its clinical risk factors. STUDY DESIGN: Retrospective cohort study of PD-associated peritonitis. SETTING & PARTICIPANTS: US Renal Data System standard analysis files were used for claims, eligibility, modality, and demographic information. The sample consisted of patients receiving PD treated at some time between 2013 and 2017 who were covered by Medicare fee-for-service (FFS) insurance with paid claims for dialysis or hospital services. EXPOSURES/PREDICTORS: Peritonitis risk was characterized by year, age, sex, race, ethnicity, vintage of kidney replacement therapy, cause of kidney failure, and prior peritonitis episodes. OUTCOME: The major outcome was peritonitis, identified using ICD-9 and ICD-10 diagnosis codes. Closely spaced peritonitis claims (30 days) were aggregated into 1 peritonitis episode. ANALYTICAL APPROACH: Patient-level risk factors for peritonitis were modeled using Poisson regression. RESULTS: We identified 70,271 peritonitis episodes from 396,289 peritonitis claims. Although various codes were used to record an episode of peritonitis, none was used predominantly. Peritonitis episodes were often identified by multiple aggregated claims, with the mean and median claims per episode being 5.6 and 2, respectively. We found 40% of episodes were exclusively outpatient, 9% exclusively inpatient, and 16% were exclusively based on codes that do not clearly distinguish peritonitis from catheter infections/inflammation ("catheter codes"). The overall peritonitis rate was 0.54 episodes per patient-year (EPPY). The rate was 0.45 EPPY after excluding catheter codes and 0.35 EPPY when limited to episodes that only included claims from nephrologists or dialysis providers. The peritonitis rate declined by 5%/year and varied by patient factors including age (lower rates at higher ages), race (Black > White>Asian), and prior peritonitis episodes (higher rate with each prior episode). LIMITATIONS: Coding heterogeneity indicates a lack of standardization. Episodes based exclusively on catheter codes could represent false positives. Peritonitis episodes were not validated against symptoms or microbiologic data. CONCLUSIONS: PD-associated peritonitis rates decline over time and were lower among older patients. A claims-based approach offers a promising framework for the study of PD-associated peritonitis.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Young EW, Zhao J, Pisoni RL, et al. Peritoneal Dialysis-Associated Peritonitis Trends Using Medicare Claims Data, 2013-2017. Am J Kidney Dis. 2022. PMID: 36108889. doi:10.1053/j.ajkd.2022.07.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。